33 participants
A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-03-29
- Start Date:
- 2009-08-13
- Completion:
- 2013-02-18
Conditions
- Breast Cancer
Interventions
- DRUG